Nonprofit, nonpartisan journalism. Supported by readers.

Donate

Guidant

Did Boston Scientific overpay for Guidant Corp.?

While reporting on the Delta-Northwest merger last spring, I interviewed merger-and-acquisition experts who cautioned that these deals usually don’t deliver the benefits that stakeholders expect.
That appears to be the case for ano